Traws Pharma Dips as Company Expands Outbreak Drug Play
Traws Pharma was down roughly 5% early Friday, with shares near $1.40 after ending at $1.48. Small-cap biotechs slid in a softer session after U.S. jobs numbers pulled the S&P 500 and Nasdaq down at the open. Traws is a nano-cap, so even small trading can swing the shares. The company’s market cap was around $21 million on Robinhood, with early trading volume at 67,480 shares. That’s much lighter than its 542,470 average.